{"id":2482553,"date":"2024-01-17T10:02:39","date_gmt":"2024-01-17T15:02:39","guid":{"rendered":"https:\/\/www.valuewalk.com\/?p=2482553"},"modified":"2024-01-17T10:02:40","modified_gmt":"2024-01-17T15:02:40","slug":"nvidia-and-amd-optimism-getting-out-of-control","status":"publish","type":"post","link":"https:\/\/www.valuewalk.com\/nvidia-and-amd-optimism-getting-out-of-control\/","title":{"rendered":"NVIDIA and AMD: Is the Optimism Getting Out of Control?"},"content":{"rendered":"\n<p>In the financial markets when everyone thinks something will happen, usually something else happens. It&#8217;s a contrarian principle that should make value-conscious investors reluctant to buy semiconductor stocks now, especially NVIDIA (NASDAQ:NVDA) and Advanced Micro Devices (NASDAQ:AMD).<\/p>\n\n\n\n<p>Granted, the buyers were right last year as NVDA and AMD stocks <a href=\"https:\/\/www.valuewalk.com\/nvidia-stock-continues-moon-shot\/\">rallied sharply<\/a> despite their elevated valuations. In early 2024, experts on Wall Street continue to praise these two tech titans for their involvement in developing chips to power artificial intelligence (AI) applications.<\/p>\n\n\n\n<p>After a rocky start this year, chipmaker stocks are generally pushing forward, and as you might expect, some familiar names are taking the lead. Sure, letting your winners run is an age-old principle that worked well last year, but putting your chips on NVIDIA and AMD stocks now may be an overly risky bet.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Companies seek AI-driven miracles<\/h2>\n\n\n\n<p>Trends come and go, but the AI buzz evidently has staying power, at least among the corporate elite. Indeed, a recently study of chief executives by consultancy firm PwC seems to indicate that today&#8217;s CEOs expect AI to deliver <a href=\"https:\/\/finance.yahoo.com\/news\/generative-ai-is-miracle-technology-for-profit-hungry-ceos-pwc-survey-234552858.html\" rel=\"nofollow\" target=\"_blank\">miraculous results<\/a> for their bottom lines.<\/p>\n\n\n\n<p>PwC claimed that 2024 is shaping up to be the year of &#8220;business model reinvention,&#8221; presumably due to the advent of <a href=\"https:\/\/www.valuewalk.com\/openai-soap-opera-stock-benefit-from-turmoil\/\">generative AI<\/a> technology. CEOs apparently concur with this sentiment as 68% of them, according to the PwC survey, expect generative AI to &#8220;significantly change&#8221; the way their company &#8220;creates, delivers and captures value.&#8221;<\/p>\n\n\n\n<p>The bar has already been set quite high, with PwC forecasting that generative AI will boost the U.S.&#8217;s gross domestic product (GDP) by around 14.5%. Moreover, 61% of U.S. CEOs anticipate that generative AI will &#8220;improve the quality of&#8221; their companies&#8217; products or services.<\/p>\n\n\n\n<p>Morgan Stanley (NYSE:MS) analyst Keith Weiss appears to believe that all of this expected AI-driven growth isn&#8217;t priced into stocks.<\/p>\n\n\n\n<p>&#8220;The potential rewards from large and transformative impacts of GenAI still outweigh the rising investor expectations implied by solid CY23 stock performance,&#8221; Weiss asserted. &#8220;On the balance, we are just getting started.&#8221; <\/p>\n\n\n\n<p>Is Weiss actually suggesting that, after a roughly 127% gain in AMD stock and a 239% rally for NVDA stock last year, the growth is &#8220;just getting started&#8221;? On the face of it, this may be a tough proposition for value-conscious investors to accept.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Price targets on the rise<\/h2>\n\n\n\n<p>With consensus optimism typically comes fulsome praise for popular companies and price-target hikes for their respective stocks. NVIDIA and Advanced Micro Devices are certainly no exceptions, and it&#8217;s easy for retail investors to get caught up in the hype.<\/p>\n\n\n\n<p>For example, Barclays (NYSE:BCS) analysts led by Tom O&#8217;Malley remain firmly in the bullish camp. They <a href=\"https:\/\/finance.yahoo.com\/news\/nvidia-amd-shares-jump-ai-164913402.html\" rel=\"nofollow\" target=\"_blank\">acknowledge<\/a> NVIDIA&#8217;s dominant position in the advanced AI chip market but also expect AMD to gain ground. Consequently, the Barclays analysts raised their price target on AMD stock from $120 all the way up to $200.<\/p>\n\n\n\n<p>Meanwhile, KeyBanc Capital Markets analyst John Vinh <a href=\"https:\/\/www.barrons.com\/articles\/amd-keybanc-optimistic-outlook-ai-demand-053c47eb\" rel=\"nofollow\" target=\"_blank\">hiked<\/a> his price targets from $170 to $195 for AMD stock and from $650 to $740 for NVIDIA stock. Again, the expectations are high as Vinh (per Barron&#8217;s) envisions NVIDIA&#8217;s B100 AI chip &#8220;to be released during the third quarter with 50% better performance than its predecessor and 40% higher pricing.&#8221;<\/p>\n\n\n\n<p>Vinh also has high hopes for AMD&#8217;s MI300 AI chip lineup. According to the KeyBanc analyst&#8217;s revised estimate, there could &#8220;be as much as $8 billion in demand for AMD\u2019s MI300 this year,&#8221; versus his &#8220;prior estimate range of $3 billion to $4 billion.&#8221;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Mind your valuations&#8230; and your expectations<\/h2>\n\n\n\n<p>Price-to-earnings (P\/E) ratios aren&#8217;t the be-all, end-all, but they can serve as a rough-and-ready indicator of whether a stock may have gotten ahead of itself. Thus, after reviewing the optimistic views of a couple of prominent analysts, it&#8217;s useful to apply an old-school valuation metric to NVIDIA and AMD.<\/p>\n\n\n\n<p>Getting down to brass tacks, NVIDIA has a GAAP-measured, trailing 12-month P\/E ratio of <a href=\"https:\/\/seekingalpha.com\/symbol\/NVDA\/valuation\/metrics\" rel=\"nofollow\" target=\"_blank\">around 72<\/a>, versus the sector median P\/E ratio of 27.72. Meanwhile, AMD&#8217;s trailing P\/E ratio is a mind-boggling <a href=\"https:\/\/seekingalpha.com\/symbol\/AMD\/valuation\/metrics\" rel=\"nofollow\" target=\"_blank\">1,238<\/a>.<\/p>\n\n\n\n<p>I double-checked AMD&#8217;s <a href=\"https:\/\/www.google.com\/finance\/quote\/AMD:NASDAQ\" target=\"_blank\">P\/E ratio<\/a>, and that jaw-dropping figure appears to be accurate. This suggests that NVIDIA and AMD do indeed have strong earnings, but their share-price appreciation has been much stronger. In light of this &#8212; and despite the notable price-target hikes &#8212; it&#8217;s not a terrible idea to take profits on these high-flying chipmaker stocks.<\/p>\n ","protected":false},"excerpt":{"rendered":"<p>In the financial markets when everyone thinks something will happen, usually something else happens. It&#8217;s a contrarian principle that should &#8230; <a title=\"NVIDIA and AMD: Is the Optimism Getting Out of Control?\" class=\"read-more\" href=\"https:\/\/www.valuewalk.com\/nvidia-and-amd-optimism-getting-out-of-control\/\" aria-label=\"More on NVIDIA and AMD: Is the Optimism Getting Out of Control?\">Read more<\/a><\/p>\n","protected":false},"author":22185,"featured_media":2482625,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[10463],"tags":[663514,667151,659696],"states":[],"acf":[],"modified_by":"Umair Tariq","_links":{"self":[{"href":"https:\/\/www.valuewalk.com\/wp-json\/wp\/v2\/posts\/2482553"}],"collection":[{"href":"https:\/\/www.valuewalk.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.valuewalk.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.valuewalk.com\/wp-json\/wp\/v2\/users\/22185"}],"replies":[{"embeddable":true,"href":"https:\/\/www.valuewalk.com\/wp-json\/wp\/v2\/comments?post=2482553"}],"version-history":[{"count":61,"href":"https:\/\/www.valuewalk.com\/wp-json\/wp\/v2\/posts\/2482553\/revisions"}],"predecessor-version":[{"id":2482630,"href":"https:\/\/www.valuewalk.com\/wp-json\/wp\/v2\/posts\/2482553\/revisions\/2482630"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.valuewalk.com\/wp-json\/wp\/v2\/media\/2482625"}],"wp:attachment":[{"href":"https:\/\/www.valuewalk.com\/wp-json\/wp\/v2\/media?parent=2482553"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.valuewalk.com\/wp-json\/wp\/v2\/categories?post=2482553"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.valuewalk.com\/wp-json\/wp\/v2\/tags?post=2482553"},{"taxonomy":"states","embeddable":true,"href":"https:\/\/www.valuewalk.com\/wp-json\/wp\/v2\/states?post=2482553"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}